RU2249590C2 - Активаторы изоиндолин-1-он-глюкокиназы - Google Patents
Активаторы изоиндолин-1-он-глюкокиназы Download PDFInfo
- Publication number
- RU2249590C2 RU2249590C2 RU2003120512/04A RU2003120512A RU2249590C2 RU 2249590 C2 RU2249590 C2 RU 2249590C2 RU 2003120512/04 A RU2003120512/04 A RU 2003120512/04A RU 2003120512 A RU2003120512 A RU 2003120512A RU 2249590 C2 RU2249590 C2 RU 2249590C2
- Authority
- RU
- Russia
- Prior art keywords
- oxo
- cyclohexyl
- dihydroisoindol
- ylpropionamide
- propionamide
- Prior art date
Links
- 0 *CC(C(N*)=O)N(CC1C2CCCC1)C2=O Chemical compound *CC(C(N*)=O)N(CC1C2CCCC1)C2=O 0.000 description 2
- RLBRXNUSTWYTMA-UHFFFAOYSA-N Cc1ccc(NC(C(CC2CCCCC2)N(Cc2c3cccc2)C3=O)=O)nc1 Chemical compound Cc1ccc(NC(C(CC2CCCCC2)N(Cc2c3cccc2)C3=O)=O)nc1 RLBRXNUSTWYTMA-UHFFFAOYSA-N 0.000 description 1
- SLCOTHPFAXVLDC-UHFFFAOYSA-N O=C(C(CC1CCCCC1)N(Cc(cc1Cl)c2cc1Cl)C2=O)Nc([s]1)ncc1Cl Chemical compound O=C(C(CC1CCCCC1)N(Cc(cc1Cl)c2cc1Cl)C2=O)Nc([s]1)ncc1Cl SLCOTHPFAXVLDC-UHFFFAOYSA-N 0.000 description 1
- IVCSEFFRVLCXQL-UHFFFAOYSA-N O=C(C(CC1CCCCC1)N(Cc(cc1Cl)c2cc1Cl)C2=O)Nc1ncc[s]1 Chemical compound O=C(C(CC1CCCCC1)N(Cc(cc1Cl)c2cc1Cl)C2=O)Nc1ncc[s]1 IVCSEFFRVLCXQL-UHFFFAOYSA-N 0.000 description 1
- XDZPUUOXMDFXIF-UHFFFAOYSA-N O=C(C(CC1CCCCC1)N(Cc1c2cccc1)C2=O)Nc(nc1)ccc1Cl Chemical compound O=C(C(CC1CCCCC1)N(Cc1c2cccc1)C2=O)Nc(nc1)ccc1Cl XDZPUUOXMDFXIF-UHFFFAOYSA-N 0.000 description 1
- VEMZDALOYZQAEW-UHFFFAOYSA-N O=C(C(CC1CCCCC1)N(Cc1c2cccc1)C2=O)Nc1ccc(cccc2)c2n1 Chemical compound O=C(C(CC1CCCCC1)N(Cc1c2cccc1)C2=O)Nc1ccc(cccc2)c2n1 VEMZDALOYZQAEW-UHFFFAOYSA-N 0.000 description 1
- UFDHBDMSHIXOKF-UHFFFAOYSA-N OC(C(CCCC1)=C1C(O)=O)=O Chemical compound OC(C(CCCC1)=C1C(O)=O)=O UFDHBDMSHIXOKF-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25527300P | 2000-12-13 | 2000-12-13 | |
| US60/255,273 | 2000-12-13 | ||
| US31871501P | 2001-09-13 | 2001-09-13 | |
| US60/318,715 | 2001-09-13 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2003120512A RU2003120512A (ru) | 2004-12-27 |
| RU2249590C2 true RU2249590C2 (ru) | 2005-04-10 |
Family
ID=26944583
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2003120512/04A RU2249590C2 (ru) | 2000-12-13 | 2001-12-07 | Активаторы изоиндолин-1-он-глюкокиназы |
Country Status (35)
| Country | Link |
|---|---|
| US (1) | US6482951B2 (https=) |
| EP (1) | EP1349856B1 (https=) |
| JP (1) | JP4021766B2 (https=) |
| KR (1) | KR100520651B1 (https=) |
| CN (1) | CN1247574C (https=) |
| AT (1) | ATE297922T1 (https=) |
| AU (2) | AU3841502A (https=) |
| BG (1) | BG107903A (https=) |
| BR (1) | BR0116169A (https=) |
| CA (1) | CA2430579C (https=) |
| CY (1) | CY1105587T1 (https=) |
| CZ (1) | CZ20031882A3 (https=) |
| DE (1) | DE60111570T2 (https=) |
| DK (1) | DK1349856T3 (https=) |
| EG (1) | EG24358A (https=) |
| ES (1) | ES2243578T3 (https=) |
| HR (1) | HRP20030450B1 (https=) |
| HU (1) | HUP0400587A3 (https=) |
| IL (2) | IL156264A0 (https=) |
| MA (1) | MA26973A1 (https=) |
| MX (1) | MXPA03005170A (https=) |
| MY (1) | MY136741A (https=) |
| NO (1) | NO325810B1 (https=) |
| NZ (1) | NZ526236A (https=) |
| PA (1) | PA8534601A1 (https=) |
| PE (1) | PE20020593A1 (https=) |
| PL (1) | PL366006A1 (https=) |
| PT (1) | PT1349856E (https=) |
| RS (1) | RS50933B (https=) |
| RU (1) | RU2249590C2 (https=) |
| SI (1) | SI1349856T1 (https=) |
| SK (1) | SK8732003A3 (https=) |
| TW (1) | TWI294876B (https=) |
| UY (1) | UY27069A1 (https=) |
| WO (1) | WO2002048106A2 (https=) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2693698C2 (ru) * | 2013-05-27 | 2019-07-04 | Ф. Хоффманн-Ля Рош Аг | Новые соединения 3,4-дигидро-2н-изохинолин-1-она и 2,3-дигидроизоиндол-1-она |
Families Citing this family (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0102299D0 (sv) | 2001-06-26 | 2001-06-26 | Astrazeneca Ab | Compounds |
| SE0102764D0 (sv) | 2001-08-17 | 2001-08-17 | Astrazeneca Ab | Compounds |
| RU2309956C2 (ru) | 2002-10-03 | 2007-11-10 | Ф.Хоффманн-Ля Рош Аг | Производные индол-3-карбоксамида в качестве активаторов глюкокиназы |
| BR0314864A (pt) | 2002-10-03 | 2005-08-02 | Novartis Ag | Compostos orgânicos |
| GB0226931D0 (en) | 2002-11-19 | 2002-12-24 | Astrazeneca Ab | Chemical compounds |
| AU2003294376A1 (en) * | 2003-01-06 | 2004-08-10 | Eli Lilly And Company | Heteroaryl compounds |
| PL378117A1 (pl) * | 2003-02-11 | 2006-03-06 | Prosidion Limited | Tricyklopodstawione związki amidowe |
| WO2004072066A1 (en) * | 2003-02-11 | 2004-08-26 | Prosidion Limited | Tri(cyclo) substituted amide glucokinase activator compounds |
| US7320992B2 (en) * | 2003-08-25 | 2008-01-22 | Amgen Inc. | Substituted 2,3-dihydro-1h-isoindol-1-one derivatives and methods of use |
| US7750020B2 (en) | 2004-04-02 | 2010-07-06 | Novartis Ag | Sulfonamide-thiazolpyridine derivatives as glucokinase activators useful the treatment of Type 2 diabetes |
| AU2005229415B2 (en) * | 2004-04-02 | 2009-05-14 | Novartis Ag | Thiazolopyridine derivatives, pharmaceutical conditions containing them and methods of treating glucokinase mediated conditions |
| CA2614746C (en) | 2005-07-09 | 2011-05-10 | Astrazeneca Ab | Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes |
| CA2621227A1 (en) * | 2005-08-31 | 2007-03-08 | Astellas Pharma Inc. | Thiazole derivative |
| JP2007063225A (ja) * | 2005-09-01 | 2007-03-15 | Takeda Chem Ind Ltd | イミダゾピリジン化合物 |
| JP2009509988A (ja) | 2005-09-29 | 2009-03-12 | サノフィ−アベンティス | フェニル−及びピリジニル−１，２，４−オキサジアゾロン誘導体、その製造方法、及び医薬品としてのその使用 |
| GT200600429A (es) * | 2005-09-30 | 2007-04-30 | Compuestos organicos | |
| GT200600428A (es) * | 2005-09-30 | 2007-05-21 | Compuestos organicos | |
| WO2007053662A1 (en) * | 2005-11-01 | 2007-05-10 | Janssen Pharmaceutica N.V. | Dihydroisoindolones as allosteric modulators of glucokinase |
| WO2007053503A1 (en) * | 2005-11-01 | 2007-05-10 | Janssen Pharmaceutica N.V. | Substituted dihydroisoindolones as allosteric modulators of glucokinase |
| CA2627910A1 (en) * | 2005-11-01 | 2007-05-10 | Janssen Pharmaceutica N.V. | Substituted cycloalkylpyrrolones as allosteric modulators of glucokinase |
| WO2007053657A1 (en) * | 2005-11-01 | 2007-05-10 | Janssen Pharmaceutica N.V. | Substituted pyrrolones as allosteric modulators of glucokinase |
| JP2009514835A (ja) * | 2005-11-03 | 2009-04-09 | プロシディオン・リミテッド | トリシクロ置換型アミド |
| JP2009515997A (ja) * | 2005-11-18 | 2009-04-16 | タケダ サン ディエゴ インコーポレイテッド | グルコキナーゼ活性剤 |
| US8034822B2 (en) | 2006-03-08 | 2011-10-11 | Takeda San Diego, Inc. | Glucokinase activators |
| PE20110235A1 (es) | 2006-05-04 | 2011-04-14 | Boehringer Ingelheim Int | Combinaciones farmaceuticas que comprenden linagliptina y metmorfina |
| EP2049518B1 (en) * | 2006-05-31 | 2011-08-31 | Takeda San Diego, Inc. | Indazole and isoindole derivatives as glucokinase activating agents. |
| WO2008074694A1 (en) * | 2006-12-20 | 2008-06-26 | F. Hoffmann-La Roche Ag | Crystallization of glucokinase activators |
| US8163779B2 (en) | 2006-12-20 | 2012-04-24 | Takeda San Diego, Inc. | Glucokinase activators |
| TW200831081A (en) * | 2006-12-25 | 2008-08-01 | Kyorin Seiyaku Kk | Glucokinase activator |
| MX2009009525A (es) * | 2007-03-07 | 2009-09-16 | Kyorin Seiyaku Kk | Activador de glucocinasa. |
| US8173645B2 (en) * | 2007-03-21 | 2012-05-08 | Takeda San Diego, Inc. | Glucokinase activators |
| PE20091313A1 (es) * | 2008-01-15 | 2009-09-03 | Lilly Co Eli | (r)-2-(4-ciclopropansulfonil-fenil)-n-pirazin-2-il-3-(tetrahidropiran-4-il)-propionamida cristalina |
| KR20100110367A (ko) * | 2008-01-24 | 2010-10-12 | 메르크 파텐트 게엠베하 | 당뇨병 치료를 위한 베타-아미노산 유도체들 |
| SI2275414T1 (sl) | 2008-04-28 | 2015-10-30 | Kyorin Pharmaceutical Co., Ltd., | Ciklopentilakrilamidni derivat |
| BRPI0912802A2 (pt) * | 2008-05-16 | 2015-10-13 | Takeda San Diego Inc | ativadores de glicoquinase |
| KR101258331B1 (ko) * | 2008-09-11 | 2013-04-26 | 화이자 인코포레이티드 | 헤테로아릴 아미드 유도체 및 글루코키나제 활성화제로서의 그의 용도 |
| CA2800498C (en) | 2010-03-31 | 2021-11-16 | The Scripps Research Institute | Reprogramming cells |
| US8178689B2 (en) * | 2010-06-17 | 2012-05-15 | Hoffman-La Roche Inc. | Tricyclic compounds |
| US20130156720A1 (en) | 2010-08-27 | 2013-06-20 | Ironwood Pharmaceuticals, Inc. | Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| ES2664873T3 (es) | 2011-03-01 | 2018-04-23 | Synergy Pharmaceuticals Inc. | Proceso de preparación de agonistas de guanilato ciclasa C |
| US8470866B2 (en) * | 2011-05-03 | 2013-06-25 | Hoffmann-La Roche Inc. | Isoindolinone derivatives |
| SI3004138T1 (sl) | 2013-06-05 | 2024-07-31 | Bausch Health Ireland Limited | Ultra čisti agonisti gvanilat ciklaze C, postopek za njihovo pripravo in uporabo |
| KR102431436B1 (ko) | 2014-08-29 | 2022-08-10 | 테스 파마 에스.알.엘. | α-아미노-β-카복시뮤콘산 세미알데히드 데카복실라제의 억제제 |
| AR109950A1 (es) | 2016-10-14 | 2019-02-06 | Tes Pharma S R L | INHIBIDORES DE LA ÁCIDO a-AMINO-b-CARBOXIMUCÓNICO SEMIALDEHÍDO DESCARBOXILASA |
| AR117122A1 (es) | 2018-11-20 | 2021-07-14 | Tes Pharma S R L | INHIBIDORES DE LA ÁCIDO a-AMINO-b-CARBOXIMUCÓNICO SEMIALDEHÍDO DESCARBOXILASA |
| CN116283717B (zh) * | 2023-01-06 | 2025-04-08 | 暨南大学 | 一种藁本内酯衍生物及其制备方法和应用 |
| WO2024229228A2 (en) * | 2023-05-02 | 2024-11-07 | The Rockefeller University | 1-oxoisoindolin-2-yl amide activators of vcp and derivatives thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5200408A (en) * | 1992-02-11 | 1993-04-06 | Laboratoires Upsa | Analgesic α-amino-N-pyridylbenzenepropanamide derivatives and pharmaceutical compositions containing them |
| RU2143424C1 (ru) * | 1995-06-06 | 1999-12-27 | Пфайзер Инк. | Замещенные n-(индол-2-карбонил)-глицинамиды и их производные, способы лечения и фармкомпозиция |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI1169312T1 (en) | 1999-03-29 | 2005-02-28 | F. Hoffmann-La Roche Ag | Glucokinase activators |
| AU2001252270B2 (en) | 2000-05-03 | 2005-12-15 | F. Hoffmann-La Roche Ag | Hydantoin-containing glucokinase activators |
| AU778036B2 (en) | 2000-05-08 | 2004-11-11 | F. Hoffmann-La Roche Ag | Substituted phenylacetamides and their use as glucokinase activators |
-
2001
- 2001-12-06 US US10/010,978 patent/US6482951B2/en not_active Expired - Fee Related
- 2001-12-07 AU AU3841502A patent/AU3841502A/xx active Pending
- 2001-12-07 CA CA2430579A patent/CA2430579C/en not_active Expired - Fee Related
- 2001-12-07 CN CNB018206107A patent/CN1247574C/zh not_active Expired - Fee Related
- 2001-12-07 JP JP2002549637A patent/JP4021766B2/ja not_active Expired - Fee Related
- 2001-12-07 KR KR10-2003-7007869A patent/KR100520651B1/ko not_active Expired - Fee Related
- 2001-12-07 SI SI200130381T patent/SI1349856T1/xx unknown
- 2001-12-07 PL PL01366006A patent/PL366006A1/xx unknown
- 2001-12-07 HR HR20030450A patent/HRP20030450B1/xx not_active IP Right Cessation
- 2001-12-07 NZ NZ526236A patent/NZ526236A/xx unknown
- 2001-12-07 ES ES01986857T patent/ES2243578T3/es not_active Expired - Lifetime
- 2001-12-07 AT AT01986857T patent/ATE297922T1/de active
- 2001-12-07 RU RU2003120512/04A patent/RU2249590C2/ru not_active IP Right Cessation
- 2001-12-07 SK SK873-2003A patent/SK8732003A3/sk unknown
- 2001-12-07 MX MXPA03005170A patent/MXPA03005170A/es active IP Right Grant
- 2001-12-07 HU HU0400587A patent/HUP0400587A3/hu unknown
- 2001-12-07 DE DE60111570T patent/DE60111570T2/de not_active Expired - Lifetime
- 2001-12-07 DK DK01986857T patent/DK1349856T3/da active
- 2001-12-07 CZ CZ20031882A patent/CZ20031882A3/cs unknown
- 2001-12-07 IL IL15626401A patent/IL156264A0/xx unknown
- 2001-12-07 PT PT01986857T patent/PT1349856E/pt unknown
- 2001-12-07 EP EP01986857A patent/EP1349856B1/en not_active Expired - Lifetime
- 2001-12-07 RS YUP-477/03A patent/RS50933B/sr unknown
- 2001-12-07 AU AU2002238415A patent/AU2002238415B2/en not_active Ceased
- 2001-12-07 WO PCT/EP2001/014404 patent/WO2002048106A2/en not_active Ceased
- 2001-12-07 BR BR0116169-5A patent/BR0116169A/pt not_active Application Discontinuation
- 2001-12-10 EG EG20011316A patent/EG24358A/xx active
- 2001-12-10 TW TW090130510A patent/TWI294876B/zh not_active IP Right Cessation
- 2001-12-10 PA PA20018534601A patent/PA8534601A1/es unknown
- 2001-12-11 PE PE2001001234A patent/PE20020593A1/es not_active Application Discontinuation
- 2001-12-11 MY MYPI20015613A patent/MY136741A/en unknown
- 2001-12-12 UY UY27069A patent/UY27069A1/es not_active Application Discontinuation
-
2003
- 2003-06-02 IL IL156264A patent/IL156264A/en not_active IP Right Cessation
- 2003-06-12 MA MA27197A patent/MA26973A1/fr unknown
- 2003-06-12 NO NO20032674A patent/NO325810B1/no not_active IP Right Cessation
- 2003-06-13 BG BG107903A patent/BG107903A/bg unknown
-
2005
- 2005-09-15 CY CY20051101133T patent/CY1105587T1/el unknown
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5200408A (en) * | 1992-02-11 | 1993-04-06 | Laboratoires Upsa | Analgesic α-amino-N-pyridylbenzenepropanamide derivatives and pharmaceutical compositions containing them |
| RU2143424C1 (ru) * | 1995-06-06 | 1999-12-27 | Пфайзер Инк. | Замещенные n-(индол-2-карбонил)-глицинамиды и их производные, способы лечения и фармкомпозиция |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2693698C2 (ru) * | 2013-05-27 | 2019-07-04 | Ф. Хоффманн-Ля Рош Аг | Новые соединения 3,4-дигидро-2н-изохинолин-1-она и 2,3-дигидроизоиндол-1-она |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2249590C2 (ru) | Активаторы изоиндолин-1-он-глюкокиназы | |
| AU2001270494B2 (en) | Alkynyl phenyl heteroaromatic glucokinase activators | |
| AU2002238415A1 (en) | Isoindolin-1-one glucokinase activators | |
| KR100519826B1 (ko) | 파라-아민 치환된 페닐아미드 글루코키나제 활성화제 | |
| JP4390704B2 (ja) | グルコキナーゼ（ｇｋ）活性化物質としてのインドール−３−カルボキシアミド | |
| AU2001270494A1 (en) | Alkynyl phenyl heteroaromatic glucokinase activators | |
| ZA200304265B (en) | Isoindolin-1-one glucokinase activators. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20101208 |